Robert A. Vescio, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Robert A. Vescio, MD

Robert A. Vescio, MD

Healthcare Professional
Director
Multiple Myeloma and Amyloidosis Program
Cedars-Sinai Medical Center
8700 Beverly Blvd. Suite AC1049
Los Angeles, California, United States
Robert A. Vescio is a medical director at multiple myeloma and amyloidosis program in the Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai. He earned his medical degree from University of California, San Diego School of Medicine followed by residency and post doctorate from the same university. Dr. Vescio then completed fellowship from University of California, Los Angeles (UCLA) Medical Center.
 
Dr. Vescio is a specialist in internal medicine, hematology and oncology. His clinical areas include amyloidosis and multiple myeloma. His research interests include monoclonal gammopathy of undetermined significance, a related condition which in some cases develop into multiple myeloma. His laboratory work has led to an improved understanding of multiple myeloma pathogenesis, including a potential link with human herpes virus-8 infection. Dr. Vescio has been cited as one of the top specialists in multiple myeloma and amyloidosis in “America’s Top Doctors for Cancer.”
 
 
Representative Publications:
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close